The Form 4 filing, an SEC report of an insider's stock activity, was submitted on October 14, 2026. The trade took place the day before, on October 13.
Transaction details
| Transaction | |
|---|---|
| Date of Earliest Transaction | 2026-10-13 |
| Date of Latest Transaction | 2026-10-13 |
| Buy/Sell | sell |
| Transaction Count | 1 |
| Shares Transacted | 4,000 |
| Price | $7.18 |
| Total Transaction Value | $28,727.20 |
| Insider | |
| Ticker Symbol | SOPH |
| Company | SOPHiA GENETICS SA |
| Insider Name | Xu Zhenyu |
| Insider Title | Chief Scientific Officer |
| Sector - Industry | Other - Unclassified |
| Holdings | |
| Total Shares Owned After Transaction | 541,493 |
| Position Size Change | 0.73% |
| Filing | |
| Filing Date | 2026-10-14 |
| SEC Link | View filing |
FAQ
What type of transaction is this?
This was a sale of 4,000 SOPH shares by Xu Zhenyu, chief scientific officer of SOPHiA GENETICS SA. It was reported as one transaction with SEC code S, which identifies a sale.
What was the average price of the transaction?
The average price was $7.1818 per share. The $7.18 price shown in the transaction details rounds that average to the nearest cent. Both figures describe the same reported sale.
How did this transaction affect the insider's holdings?
The sale reduced reported holdings by 4,000 shares, leaving 541,493 shares owned afterward. The shares sold made up 0.73% of the shares owned before the sale.
What's the total transaction value?
The total transaction value was $28,727.20. That amount covers all 4,000 shares in the single reported sale.
Are there any special circumstances around this transaction?
The available filing information indicates a possible link to a Rule 10b5-1 trading plan. These plans set trading instructions in advance. No footnote text is available to confirm whether the plan covers this specific sale. The plan's start date and trading schedule are unknown.
For research purposes only; not investment advice.